Case Report
BibTex RIS Cite
Year 2021, Volume: 3 Issue: Supplement 1, 55 - 56, 07.03.2021
https://doi.org/10.46310/tjim.875351

Abstract

References

  • 1.Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:538-48.
  • 2. Kyle RA. Multiple myeloma: revive of 869 cases. Mayo Clinic Proc 1975;50: 29-40.
  • 3.Kyle RA, Gertz MA, Witzing TE, et al. Reviewof 1027 patients with newly diagnosed multiple myeloma. Mayo Clinic Proc 2003;78:21-33.
  • 4.Kapadia SB. Multiple myeloma: a clinicopathologic studyof 62 consecutively autopsied cases . Medicine(Balt) 1980; 59: 380-392.
  • 5. Blade J, Fernandez-Llama P, Bosch F, et al. Renal Failure in multiple myeloma: presenting features and predictors of outcome in 94 patient from a single institution. Acrh Intern Med 1998; 158: 1889-1893.
  • 6. Knudsen LM, Hippe E, Hjort M, et al. Renal function in newly diagnosed multiple myeloma – a demographic study of 1353 patients. The Nordic Myeloma Study Group. Eur J Haematol 1994; 53: 207-212.
  • 7. Irish AB, Winearls CG, Littlewood T. Presentation and survival of patients with severe renal failure and nyeloma. Q J Med 1997;90: 773-780.
  • 8. Kyle RA, Therneau TM, Rajkumar SV, et al. Incidence of multiple myeloma in Olmsted County, Minnesota: trend over 6 decades. Cancer. 2004; 101:2667-74.

An Unforgettable Pre-Diagnosis for an Elderly Patient with Renal Failure and Back Pain: Multiple Myeloma

Year 2021, Volume: 3 Issue: Supplement 1, 55 - 56, 07.03.2021
https://doi.org/10.46310/tjim.875351

Abstract

Multiple myeloma is a malignant disease that can result in organ damage due to abnormal plasma cell growth and immunoglobulin or light chain overproduction in the bone marrow. It is the second most common hematologic cancer after lymphomas. Approximately half of the patients have kidney failure. Bone involvement is one of the most common organ damage in myeloma. Bone involvement is a feature that has diagnostic and prognostic value, shows tumor burden, organ damage, and affects the patient's quality of life. With the recent advances in Multiple Myeloma treatment, the survival of patients has increased dramatically. Although new agents contribute positively to total survival and disease-free life span, they cannot prevent disease recurrence. Therefore, it should be considered in patients with back pain, anemia, and kidney failure, and treatment delay should be avoided.

References

  • 1.Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:538-48.
  • 2. Kyle RA. Multiple myeloma: revive of 869 cases. Mayo Clinic Proc 1975;50: 29-40.
  • 3.Kyle RA, Gertz MA, Witzing TE, et al. Reviewof 1027 patients with newly diagnosed multiple myeloma. Mayo Clinic Proc 2003;78:21-33.
  • 4.Kapadia SB. Multiple myeloma: a clinicopathologic studyof 62 consecutively autopsied cases . Medicine(Balt) 1980; 59: 380-392.
  • 5. Blade J, Fernandez-Llama P, Bosch F, et al. Renal Failure in multiple myeloma: presenting features and predictors of outcome in 94 patient from a single institution. Acrh Intern Med 1998; 158: 1889-1893.
  • 6. Knudsen LM, Hippe E, Hjort M, et al. Renal function in newly diagnosed multiple myeloma – a demographic study of 1353 patients. The Nordic Myeloma Study Group. Eur J Haematol 1994; 53: 207-212.
  • 7. Irish AB, Winearls CG, Littlewood T. Presentation and survival of patients with severe renal failure and nyeloma. Q J Med 1997;90: 773-780.
  • 8. Kyle RA, Therneau TM, Rajkumar SV, et al. Incidence of multiple myeloma in Olmsted County, Minnesota: trend over 6 decades. Cancer. 2004; 101:2667-74.
There are 8 citations in total.

Details

Primary Language English
Subjects ​Internal Diseases
Journal Section Case Reports
Authors

Ece Ünal Çetin 0000-0002-0933-7764

Adil Uğur Çetin This is me 0000-0002-2640-5386

Publication Date March 7, 2021
Submission Date February 6, 2021
Acceptance Date March 6, 2021
Published in Issue Year 2021 Volume: 3 Issue: Supplement 1

Cite

EndNote Ünal Çetin E, Çetin AU (March 1, 2021) An Unforgettable Pre-Diagnosis for an Elderly Patient with Renal Failure and Back Pain: Multiple Myeloma. Turkish Journal of Internal Medicine 3 Supplement 1 55–56.

e-ISSN: 2687-4245 

Turkish Journal of Internal Medicine, hosted by Turkish JournalPark ACADEMIC, is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

by-nc-nd.png
2024 -TJIM.org